Skip to main content

In Brief This Week: Thermo Fisher Scientific; Biotools, BlackBio; Evotec, Cubist Pharmaceuticals; Source BioScience; London Genetics; NHGRI

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific has completed its acquisition of Ahura Scientific, a maker of Raman and FT-IR spectroscopy instruments. The acquired company will be integrated into Thermo Fisher's Analytical Technologies Segment.

Biotools said that it has spun out a personalized medicine tools firm called BlackBio. The new firm will use sequencing platforms, protein arrays, and other molecular tools in researching metabolic disorders, cancer, cardiovascular diseases, pharmacogenetics, and other areas.

Evotec this week said that it has extended an agreement with Cubist Pharmaceuticals, under which it is using its EVOlution platform for fragment screening and protein crystallography to discover new compounds against antibacterial targets selected by Cubist.

Source BioScience has opened a new DNA sequencing service laboratory in Dublin, Ireland. The lab is located on the campus of Trinity College. Source said that it will offer DNA sequencing services to customers within the university, including access to its next-generation sequencing and genotyping platforms at its central lab hub in Nottingham, UK.

London Genetics, a non-profit company established in 2007 to promote the use of pharmacogenetics in drug discovery and development, has made the first three awards from its proof-of-concept fund. Projects funded through the program are intended to illustrate the value of using genetic data and resources from London Genetics' seven academic founding members in drug discovery and development. The first three awards went to teams at imperial College London and University College London for projects focused on immunotherapy, schizophrenia, and heart disease.

The Baltimore building that is home to the National Human Genome Research Institute and two other groups of the National Institutes of Health is being acquired by a Scottsdale, Ariz., real estate investment trust.

Healthcare Trust of America announced it will pay about $29.3 million for the 101,400-square-foot Triad Technology Center under a purchase and sale agreement with an undisclosed seller. The closing of the sale "is subject to the satisfaction of a number of conditions," HTA said in a statement.

The Scan

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.